The company
Regentis Biomaterials Ltd.
RGNT · NYSE American
RGNT stood above a rising 150-day average in 0 of the last 10 weekly readings. It is 40.6% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 10
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 6 (+3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 10 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Rosalind Advisors, Inc.added · filed 14 Aug 2026 | 701,685$2.5M | +450,175+179.0% |
| Warberg Asset Management LLCnew · filed 11 Aug 2026 | 86,980$306K | +86,980 |
| JANE STREET GROUP, LLCnew · filed 14 Aug 2026 | 43,333$153K | +43,333 |
| RENAISSANCE TECHNOLOGIES LLCnew · filed 13 Aug 2026 | 13,348$47K | +13,348 |
| UBS Group AGadded · filed 13 Aug 2026 | 434$1,532 | +100+29.9% |
| Tower Research Capital LLC (TRC)new · filed 11 Aug 2026 | 11$39 | +11 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.